Tracheal intubation is a common procedure in intensive care. Delayed recognition of oesophageal intubation is associated with serious iatrogenic morbidity and mortality. Oesophageal placement of an endotracheal tube (ETT) during the emergency airway management of critically ill patients is reported to occur in 8% of attempts 1 . End-tidal carbon dioxide (F É CO 2 ) monitoring to assist in confirmation of ETT position in the intensive care unit (ICU) setting has been recommended 2 , but is currently not mandatory in ICUs in Australia and New Zealand. The aims of this survey were to assess the availability of F É CO 2 monitoring in ICUs approved for training purposes in Australia and New Zealand, the methods used to confirm ETT placement in the ICU setting, and the opinions of senior clinicians on the role of F É CO 2 monitoring in the ICU.
MATERIALS AND METHODS
The Joint Faculty of Intensive Care Medicine was contacted to provide a list of ICUs approved for training purposes in Australia and New Zealand 3 . Sixty-six adult and paediatric ICUs were identified, and a questionnaire (Appendix) modified from a questionnaire used in a similar study in the United Kingdom 4 was sent to the lead clinician/head of department of all 66 units. Fifty replies were received from the initial mailing, with a further eleven replies received from a follow-up mailing four weeks later. The main objectives of the survey were to determine how many ICUs had F É CO 2 monitoring available; the methods used to confirm correct ETT placement; and the number of ICUs that routinely used F É CO 2 monitoring to immediately confirm ETT placement. Secondary objectives were to canvas senior clinicians views on F É CO 2 monitoring to confirm ETT placement in critically ill patients; whether F É CO 2 monitoring should be mandatory to confirm ETT placement in ICUs; under what circumstances F É CO 2 monitoring would ideally be used; whether unit policy stipulated the mandatory use of F É CO 2 monitoring to confirm ETT placement and whether doctors with less than one year's anaesthetic experience ever provided the immediate medical cover on the ICU.
RESULTS
Sixty-one completed questionnaires were received from the 66 ICUs surveyed. This represented a 92.4% response rate.
Sixty ICUs (98.3%) had F É CO 2 monitoring available. Thirty eight (62%) of ICUs shared a F É CO 2 monitor between several beds, 22 (36%) of ICUs had one F É CO 2 monitor per bed and one ICU did not have a F É CO 2 monitor, although a bid to obtain one was in progress.
The methods for confirming correct ETT placement that were reported by the 61 ICUs are presented in Table 1 . F É CO 2 monitoring or a colorimetric device were used routinely by 44 (72.1%) of ICUs. No ICUs reported routinely using oesophageal detector devices (ODD) to assist in confirmation of ETT placement 5 .
Forty-two respondents (68.8%) would use F É CO 2 monitoring to confirm every intubation if it were available. Ten respondents (16.4%) would only use F É CO 2 monitoring for anticipated difficult intubations. Six respondents (9.8%) would only use F É CO 2 monitoring if the tube position was in doubt. Five other respondents would only use F É CO 2 monitoring in situations such as head injured patients, transport of patients and percutaneous tracheostomy insertion.
The immediate medical cover on the ICU was potentially provided by a doctor with less than one year's anaesthetic experience in 48 (78.7%) of the ICUs surveyed.
Fifty-two (83.3%) respondents thought that F É CO 2 monitoring was superior to other methods for confirming tracheal intubation in critically ill patients. Thirty-eight (62.3%) respondents thought that F É CO 2 monitoring should be mandatory to confirm tracheal intubation on ICU. Thirty-three ICUs (54.1%) had a policy in place requiring the mandatory use of F É CO 2 monitoring to confirm every tracheal intubation.
DISCUSSION
The immediate confirmation of successful tracheal intubation in the critically ill can be challenging. No single or combined method to immediately confirm correct ETT placement is both 100% sensitive and specific 6, 7, 8, 10 . This is reflected in the wide range of methods to confirm ETT placement reported in this survey.
Accepted clinical signs can often be misleading especially in critically ill patients. For anatomical reasons it is not always possible to visualize the ETT passing through the vocal cords. Chest wall movement may be difficult to assess in obese patients, those with large breasts, and those with rigid chest walls or severe lung disease. Auscultation of the chest is also often misleading with the quality and character of breath sounds differing between individuals and dependent on the rate and volume of ventilation 7 . Air passing through the oesophagus can produce vibration that can be transmitted through the lung and be mistaken for breath sounds 9 . Normal breath sounds may be transmitted to the epigastrium, and lead to inappropriate extubation. Gastric distension, condensation of water vapour in the ETT, sternal compression while listening over an open ETT, reservoir bag compliance and refill, palpation of the tracheal tube in the trachea and the use of a lighted stylet are similarly unreliable 7, 10 . Bronchoscopy has also been used to confirm ETT position, but it is not always readily available, and blood and secretions may significantly obscure the image and delay accurate diagnosis. F É CO 2 confirmation of tracheal intubation requires an adequate pulmonary blood flow and a patent airway and can be less reliable in cardiac arrest, low cardiac output states, severe airway obstruction, pulmonary embolism, severe pulmonary disease and concurrent PEEP with a poor cuff seal 7, 8, 11 . The sensitivity of F É CO 2 monitoring to confirm tracheal intubation in cardiac arrest patients has been reported as 70% in one study 12 . The oesophageal detector device may be more sensitive in these situations although failure has been reported in morbidly obese patients 10 , or with mucus plugging of the tracheal tube lumen 12 . The use of the oesophageal detector device in infants under one year has been found to be unreliable 13 .
False negative tests with F É CO 2 monitoring in cases of inadvertent oesophageal intubation have been reported. Alveolar gas may enter the stomach during mask ventilation 7, 8 , and antacids in the stomach or the recent ingestion of carbonated drinks may be misleading 14 . In these situations the detected carbon dioxide should rapidly diminish to zero after a few breaths and establish the diagnosis 7 . A normal capnograph trace or colorimetric reading may also mask an ETT positioned in the pharynx with the attendant risks of dislodgement and aspiration of gastric contents 8 .
A suggested minimum immediate check for correct placement of an ETT is auscultation over the trachea, axillae and epigastrium, together with additional secondary confirmation by either sustained F É CO 2 >4%, and/or a negative pressure test depending on the presence of a perfusing rhythm 6, 7 . No ICUs however reported ever using negative pressure oesophageal detector devices. F É CO 2 detection can be reliably achieved by either capnography or colorimetric devices although the threshold for F É CO 2 detection for the colorimetric capnometer is approximately 15 mmHg 6 . The four-phase capnography waveform pattern provides useful additional information, including detection of ventilatory problems, tube or airway obstruction, circuit disconnections and continued monitoring of tube position and should ideally be used 7 .
Minimum acceptable standards for immediate confirmation of tracheal intubation were therefore not achieved in 23 (37.7%) of ICUs. Seventeen ICUs relied solely on clinical signs, and six ICUs failed to combine appropriate clinical signs with F É CO 2 monitoring or colorimetric devices.
A large number of respondents (37.7%) felt that F É CO 2 monitoring should not be a mandatory requirement for confirming tracheal intubation in ICUs in Australia and New Zealand. F É CO 2 monitoring is however available in 98.3% of the ICUs that were surveyed and 54% of ICUs surveyed already have a policy in place requiring it be used with every intubation. Potentially inexperienced airway practitioners also sometimes provide the immediate medical cover in over three quarters of the ICUs.
Guidelines from critical care societies worldwide do however vary, with most classifying it as a desirable, but not an essential monitor 4 . F É CO 2 monitoring was not used routinely in 31.2% of ICUs to confirm tracheal intubation. Reasons may include that it is not a mandatory requirement, that F É CO 2 monitors are shared between bed spaces in most of the ICUs and therefore not always immediately available or that clinicians do not believe that they are useful in this setting.
In a similar survey conducted in the United Kingdom, 20% of ICUs did not have F É CO 2 monitoring available. Fifty per cent of ICUs used F É CO 2 monitoring to confirm tracheal tube placement but only 15% used it to confirm every intubation. Fifty per cent of respondents did not believe that F É CO 2 monitoring should be mandatory for ETT confirmation in ICU 4 . The reasons for the differences between the U.K. results and the results in this survey are not clear, but may reflect that the hospitals in the U.K. survey included non-teaching hospitals.
This survey suffers the potential drawbacks of any postal survey in that the views expressed are individual opinions and may not be reflective of the views or clinical practice of intensive care doctors as a whole. The 92.4% response rate does enhance the likelihood that the views expressed are representative.
In this survey, 37.7% of ICUs used sub-optimal methods for confirming ETT placement in intensive care patients. This should involve multiple methods of confirmation [6] [7] [8] . As a minimum it should combine appropriate clinical signs with F É CO 2 monitoring and/or the use of the oesophageal detector device which should also be available in all units. Best clinical practice needs continued promotion and highlighting. The limitations of F É CO 2 monitors for confirming correct ETT placement in the intensive care population need to be understood, but the routine use of F É CO 2 monitoring in conjunction with clinical signs and the oesophageal detector device can only enhance patient safety.
